A Memphis-based drug development company has announced $48.5 million in private placement.
GTx Inc. announced Tuesday, Sept. 26, that it had entered into a definitive securities purchase agreement for the sale of its common stock and warrants to purchase common stock in a private placement, which it expects to result in $48.5 million in proceeds before expenses. At the closing, GTx will issue and sell 5.48 million shares of common stock and warrants to purchase up to 3.29 million additional shares…
A Memphis-based drug development company has announced $48.5 million in private placement.
GTx Inc. announced Tuesday, Sept. 26, that it had entered into a definitive securities purchase agreement for the sale of its common stock and warrants to purchase common stock in a private placement, which it expects to result in $48.5 million in proceeds before expenses. At the closing, GTx will issue and sell 5.48 million shares of common stock and warrants to purchase up to 3.29 million additional shares…